Tasly Pharmaceutical Group Co.,Ltd. Posted 595.3 Million Yuan Net Loss in First Quarter of 2022

Tasly Pharmaceutical Group Co.,Ltd. (天士力医药集团股份有限公司) (600535.SH) reported a net loss of 595.3 million yuan in the first quarter of 2022, reversing a net profit of 322.9 million yuan for the same period in the previous year.

Meanwhile, the company posted 1.9 billion yuan in revenue, up 6% year-on-year.

At the end of the reporting period, it had 16.4 billion yuan in total assets and 3.7 billion yuan in total liabilities, with a liability-to-asset ratio of 22.5%.